Collagen for Menopause: What the Research Actually Shows

This content is for informational purposes only and is not medical advice. Collagenium is published by a research-driven editorial team, not licensed medical professionals. See our editorial standards and methodology. Consult a registered dietitian, physician, or pharmacist before starting any supplement, especially if you have existing health conditions, are pregnant or breastfeeding, or take medications.

Collagen for menopause has a narrow evidence base. Skin collagen and bone mass fell about 1 to 2% a year after menopause in 1987 measurements (well-supported). Peptide trials show small gains in skin elasticity (2014) and bone density in postmenopausal women (2018), mostly with one branded peptide (some evidence). Nothing supports collagen for hot flashes, sleep, mood or weight.

This is the explainer, not the shopping list. For product comparisons, see our best collagen for women over 50 guide and our collagen benefits for women by life stage article.

What does the evidence show at a glance?

Two claims hold up well, two have some support in the right population, and the rest are marketing or animal data. The table grades each claim by the strength of the human evidence and by who was actually studied.

Claim	Who was studied	What the trials found	Evidence grade
Skin collagen and bone mass fall faster after menopause	Postmenopausal women, 1980s measurements	About 1 to 2% per year loss in skin collagen, skin thickness and bone mass, all correlated (1987). “Up to 30% in the first five years” is a review estimate (2013).	Well-supported for the decline; the 30% figure is an estimate
Collagen peptides improve skin elasticity and hydration	Women aged 35 to 65 in most trials; one 2025 trial in menopausal women	Small, instrument-measured gains after 8 to 12 weeks (2014, 2015, 2025); two meta-analyses (2021, 2023) agree but flag bias and small samples	Some evidence in women around menopause; well-supported in mixed-age adults
Collagen peptides raise bone mineral density	Postmenopausal women with low bone density, five randomized trials	Small BMD gains or slower loss with 5 g daily over 12 months (2015, 2018, 2022); one 6-month trial saw no change in bone markers (2025)	Some evidence, small effects, mostly manufacturer-involved
Collagen eases menopause joint pain	No trial in menopausal women; athletes only (2008)	Indirect	Preliminary
Collagen preserves muscle after menopause	Premenopausal women doing resistance training only (2019)	Indirect	Preliminary
Collagen strengthens nails and reduces hair shedding	25 people in an open-label nail study (2017); hair shedding as a secondary outcome (2025)	No placebo comparison for nails	Preliminary
Collagen relieves hot flashes, improves sleep or mood	Nobody	No trial exists (PubMed searched 2026)	Marketing claim
Collagen limits menopausal weight gain	24 rats	Less weight gain in ovariectomized rats (2016)	Marketing claim (animal data only)

What happens to collagen during and after menopause?

Estrogen tells the fibroblasts in skin and the cells that build bone to keep making collagen, so when estrogen falls at menopause, collagen production slows while breakdown continues. Measurements in postmenopausal women published in 1987 found that skin collagen content, skin thickness, forearm bone mineral content and a hand-bone measure called the metacarpal index all declined at a similar rate of between 1 and 2% per year after menopause, and that the four measures moved together, pointing to one shared cause in the connective tissue common to skin and bone. Well-supported.

The “30% in the first five years” figure that appears on almost every page about this topic comes from the same body of 1980s work by Brincat and colleagues in London, but it is worth knowing how it is reported. A 2013 review of estrogen and skin in Dermato-Endocrinology states that skin collagen is “thought to decrease by as much as 30% in the first five years after menopause”, and in the same paragraph gives the measured rate as 2% per postmenopausal year.

The abstract of the 1987 paper itself reports 1 to 2% per year and does not state a five-year total. Read the 30% as a high-end estimate of a front-loaded decline, not as a measurement everyone has been given.

The steepest change is front-loaded into the first years after the final period, which is why skin can seem to change suddenly after decades of slow drift. The 2013 review describes the result as thinner, drier skin with less collagen, lower elasticity and more wrinkling (well-supported).

One honest gap: no trial has tested starting collagen in perimenopause to slow the decline before it happens. The skin trials enrolled women aged 35 to 65 by age, not by menopausal status, and the bone trials enrolled women who were already postmenopausal with reduced bone density. Perimenopause collagen use is therefore an extrapolation, not a tested strategy.

Does collagen help skin after menopause?

Modestly, and the best evidence is in women of the right age rather than in women confirmed to be postmenopausal. Randomized trials in women aged 35 to 65 (2014) show measurable gains in skin elasticity, hydration and eye-wrinkle depth after 8 weeks of 2.5 to 5 grams of collagen peptides a day, and one 2025 trial in menopausal women found the same direction for elasticity over six months. Some evidence for this population. The broader skin literature in mixed-age adults is well-supported because two independent meta-analyses pooling 19 and 26 randomized trials (2021, 2023) agree on direction, even though both flag small samples and incomplete data in many of the trials they pooled.

Trial	Participants	Dose and duration	Result	Funding or conflicts
Proksch 2014 (elasticity)	69 women aged 35 to 55	2.5 g or 5 g specific peptides daily, 8 weeks	Elasticity improved at both doses vs placebo; hydration trend not significant; no side effects noted	Co-author from the Collagen Research Institute, Kiel, which later disclosed manufacturer lecture support and peptide patents (2021)
Proksch 2014 (wrinkles)	114 women aged 45 to 65	2.5 g Verisol daily, 8 weeks	Eye wrinkle volume 20% lower than placebo; procollagen I up 65% in skin biopsies; effect persisted 4 weeks after stopping	Same author group
Asserin 2015	Two placebo-controlled trials, adult women	Daily peptides, 8 to 12 weeks	Hydration up at 8 weeks; dermal collagen density up from 4 weeks	Authors affiliated with Rousselot, the peptide manufacturer, and partner labs
Duangjai 2025	Menopausal women, four groups	5 g fish collagen, with or without calcium and vitamin D, 6 months	Elasticity up 12% (collagen alone) and 9% (combined); hydration up 23% (combined) vs baseline; no adverse liver or kidney signals	Authors declare no conflicts
de Miranda 2021 meta-analysis	19 RCTs, 1,125 people aged 20 to 70, 95% women	90 days typical	Favorable for hydration, elasticity and wrinkles vs placebo	Academic authors; funding not stated in abstract
Pu 2023 meta-analysis	26 RCTs, 1,721 people	Various	Hydration and elasticity improved vs placebo; missing outcome data in 13 of 26 trials; several trials under 40 people	Authors declare no conflicts

Three caveats keep the grade at “some evidence” for women around menopause. First, the effects are measured with instruments such as a cutometer and are modest; a 20% reduction in eye-wrinkle volume is detectable to a device and may or may not be visible in a mirror. Second, both Proksch trials include authors from the Collagen Research Institute in Kiel, and a 2021 paper from the same group (Zdzieblik) discloses lecture support from the peptide’s manufacturer and patents on collagen peptide use, which is a reason for independent replication rather than dismissal. Third, the 2023 meta-analysis found incomplete outcome data in half of the trials it pooled.

The trials above are the evidence for the dryness and lost elasticity that follow estrogen decline; none of them restores the estrogen signal that drove collagen production before menopause. Our collagen for skin guide explains the mechanism and realistic expectations, and collagen for loose skin covers laxity specifically.

Does collagen help bone density after menopause?

There is some evidence, and it is better than most pages admit and weaker than the headlines imply. Five randomized trials in postmenopausal women, four of them in women with osteopenia (bone density below normal but above the osteoporosis threshold), have tested about 5 grams of collagen peptides a day. Three found slightly higher bone density or slower bone loss at 12 months (2018, 2022, 2015), one found lower bone-turnover markers at 3 months (2020), and one found no change in bone markers at 6 months (2025). Some evidence. The effects are small, the trials are small, and most involved the product’s manufacturer.

Study	Women	Duration	Comparison	Product	Funding or conflicts	Result
König 2018 (RCT)	131 enrolled, 102 completed	12 months	5 g specific peptides vs placebo	Fortibone (Gelita)	“Part of the study was financially supported by GELITA AG”	Spine T-score +0.1 vs -0.03; femoral neck +0.09 vs -0.01; bone-formation marker P1NP up
Zdzieblik 2021 (follow-up)	31 completed	4 years total	All took peptides, no placebo	Fortibone	One author reports Gelita-supported lectures and collagen peptide patents	Spine and femoral neck density rose; open-label design
Argyrou 2020 (randomized)	51 with osteopenia	3 months	5 g peptides + 500 mg calcium + 400 IU D3 vs calcium + D3	Colabone (contains Fortibone)	Supported and supplied by Vivapharm SA	Bone turnover markers P1NP down 13%, CTX down 11% in the collagen group; no change in comparison group
Lampropoulou-Adamidou 2022 (randomized)	51 with osteopenia	12 months	Same groups as above	Colabone	Supported by Vivapharm SA, as above	Tibial trabecular volumetric density up 2.5%; spine density higher than comparison group
Elam 2015 (RCT)	39 with osteopenia	12 months	5 g calcium-collagen chelate vs calcium + D	Calcium-collagen chelate	Not stated in abstract	Whole-body bone loss 1.3% vs 3.8% in completers
Duangjai 2025 (randomized)	Menopausal women, four groups	6 months	5 g fish collagen, with or without calcium + D3, vs placebo	Fish collagen peptides	Authors declare no conflicts	No significant change in bone turnover markers in any group

Read the numbers, not the headlines. A spine T-score change of +0.1 against -0.03 is statistically significant and real, but it is a tenth of a standard deviation; nobody has tested whether collagen reduces fractures, which is the outcome that matters clinically. The four-year follow-up had no placebo group, so it cannot separate the supplement from everything else those 31 women did. The two Greek trials used the same branded peptide and were supported by its distributor. The one trial whose authors declare no industry conflicts ran for six months, measured blood markers rather than bone density, and found no change in those markers.

Two details matter more than the headline results. In four of the six studies the comparison group took calcium and vitamin D, which is what the investigators treated as the floor, not an optional extra. And every trial that found a bone effect enrolled women whose bone density had already been measured and found low, so collagen was tested as an addition to that pathway, never as a replacement for it. For product options that match the trial dose, see our best collagen for bone health guide.

What about joint pain, muscle, hair and nails?

For joints and muscle, there is no trial in menopausal women at all; for nails and hair, the data are thin. Joint stiffness is a common complaint in perimenopause, and collagen hydrolysate has reduced activity-related joint pain in a 24-week trial of 147 athletes taking 10 grams a day (2008), but athletes are not menopausal women, so the grade is Preliminary for this use. Our collagen for joint health guide covers that evidence.

For muscle, the trial usually cited gave 15 grams of collagen peptides daily to 77 premenopausal women doing resistance training three times a week for 12 weeks (2019) and found greater gains in fat-free mass and grip strength than training with placebo. Premenopausal is the operative word. A PubMed search on 2026-11-01 for collagen peptides with resistance training or muscle strength in postmenopausal women returned no trials. Preliminary.

For nails, the often-quoted 12% faster growth and 42% fewer broken nails come from a 2017 open-label study of 25 people taking 2.5 grams daily for 24 weeks, with no placebo group, so expectation effects cannot be ruled out. For hair, the 2025 menopausal trial reported less shedding in every supplemented group compared with placebo, including the group taking only calcium and vitamin D, which makes it hard to credit collagen. Preliminary for both.

What has collagen not been shown to do during menopause?

Hot flashes, night sweats, sleep, mood and weight. These are the symptoms most women want help with, and collagen has no human trial evidence for any of them. Collagen is a dietary protein that contains no estrogen, and we found no proposed mechanism in the literature we reviewed by which it would act on the vasomotor symptoms that estrogen loss causes. Any product implying otherwise is making a marketing claim.

• Hot flashes and night sweats: our PubMed search on 2026-11-01 for collagen supplements with hot flashes, hot flushes or vasomotor symptoms returned 26 papers, none of them a trial of collagen for these symptoms. At least one product ranking on the first page of Google for this query sells a “peri menopause” collagen drink that it says reduces hot flushes. Marketing claim.
• Sleep and mood: the equivalent search for collagen with menopause and sleep, mood or depression returned 10 papers, none a collagen supplement trial. Products that pair collagen with “beauty sleep” or “inner calm” claims are relying on added ingredients, not collagen. Marketing claim.
• Weight gain: the third-ranking result for this search on the day we checked is a 2016 paper titled “Amelioration of estrogen deficiency-induced obesity by collagen hydrolysate”. It is a 12-week study of 24 ovariectomized rats given collagen in their drinking water. Rats with their ovaries removed gained less weight on collagen; blood lipids and glucose did not change. No human trial in menopausal women shows weight change from collagen, and the 2025 six-month trial found no change in body composition in any group. Collagen may add mild fullness like any protein. Marketing claim as a weight aid.

What doses and products did the trials actually use?

Trials used 2.5 to 5 grams a day for skin and 5 grams a day for bone, almost always as hydrolyzed collagen peptides and, for bone, almost always one branded peptide. We report these figures as what was tested, not as a recommendation; dosing for your situation belongs with a dietitian or physician.

Outcome	Population	Daily dose	Duration	Product tested	Trial
Skin elasticity	Women 35 to 55	2.5 g or 5 g	8 weeks	Specific collagen peptides	Proksch 2014
Eye wrinkles, dermal procollagen	Women 45 to 65	2.5 g	8 weeks	Verisol	Proksch 2014
Skin hydration and elasticity	Menopausal women	5 g, with or without calcium + D3	6 months	Fish collagen peptides	Duangjai 2025
Bone mineral density	Postmenopausal, low BMD	5 g	12 months	Fortibone	König 2018
Bone turnover and density	Postmenopausal osteopenia	5 g + 500 mg calcium + 400 IU D3	3 to 12 months	Colabone (Fortibone)	Argyrou 2020; Lampropoulou-Adamidou 2022
Whole-body bone loss	Postmenopausal osteopenia	5 g calcium-collagen chelate	12 months	Calcium-collagen chelate	Elam 2015
Activity-related joint pain	Athletes	10 g	24 weeks	Collagen hydrolysate	Clark 2008
Muscle with training	Premenopausal women	15 g	12 weeks	Specific collagen peptides	Jendricke 2019

“Specific collagen peptides” is the term the German trials use for hydrolyzed collagen fractions of a defined size; the bone peptide averaged about 5 kilodaltons according to the 2018 trial’s methods. The peptide powders in our catalogue list 9 to 20 grams per serving (Ancient Nutrition Multi Collagen 9 g, Sports Research Marine Collagen 11 g, Orgain and Vital Proteins 20 g), which is more total collagen than the trials used but a different product. Nobody has run the bone trial with a generic peptide, so a plain powder is an inference from the same raw material, not a tested equivalent. Two products in our catalogue illustrate the choice.

Is collagen safe during menopause, and can it be taken with hormone therapy?

In the trials that enrolled postmenopausal women, nothing of concern was reported. The 12-month bone trial of 131 women recorded no adverse events and attributed none of its 29 dropouts to the supplement (2018); the 6-month menopausal trial found kidney and liver blood markers stayed within normal ranges in all groups (2025); and a 2019 systematic review of 11 dermatology trials covering 805 people at 2.5 to 10 grams a day for up to 24 weeks reported no adverse events. Well-supported for short-term tolerability at trial doses.

On hormone therapy, the honest answer is that no study has looked. We found no trial that combined collagen peptides with menopausal hormone therapy (HRT) or reported interactions. Collagen is a food-derived protein with no hormonal activity, which makes a pharmacological interaction unlikely, but “unlikely” is a reasoning, not a finding. A pharmacist can review it against your prescriptions in a few minutes. Collagen is sourced from cattle, fish or chicken, so allergies to those foods are the practical exclusion. For the full picture on tolerability and who should check first, see collagen side effects.

What should you ask your clinician before starting collagen?

Collagen was tested as an addition to standard care in women who had already been assessed, so the most useful conversation covers the assessment rather than the supplement. These are questions, not recommendations.

1. Do I need a bone density (DXA) scan? Every bone trial that found an effect enrolled women with measured low density. Knowing your own number tells you whether the bone evidence applies to you at all.
2. Are my calcium and vitamin D intake adequate? The comparison groups in four of the six bone studies took 500 mg calcium with 200 IU (2015) or 400 IU (2020, 2022, 2025) vitamin D daily as the baseline.
3. Am I getting enough total protein? Collagen is an incomplete protein and the muscle trial paired it with resistance training; neither replaces adequate dietary protein.
4. Am I a candidate for menopausal hormone therapy, and does that change the picture? The 2013 review summarizes trials in which estrogen therapy increased skin collagen and thickness (well-supported within that review), because it restores the signal collagen supplements cannot. That decision has risks and benefits well beyond skin and is a prescriber’s conversation.
5. Do I have kidney disease or a history of kidney stones? Collagen adds protein load, and the trials excluded people with significant illness, so safety in these groups is untested rather than established.
6. Could any of my medications interact with a protein supplement taken at the same time? There is no collagen-specific data; your pharmacist can check timing.
7. What would we measure, and when, to know whether it is doing anything? In the trials, skin elasticity changed by 8 weeks and bone density by 12 months. Agreeing on a checkpoint avoids open-ended spending.

How we researched this

We read the ten pages ranking on Google US for this query on 2026-11-01, then opened every trial they cited plus the trials they did not: 18 primary sources, including the 1987 Brincat paper behind the collagen-loss figures, the full text of the 2018 bone trial for its funding statement, and four postmenopausal bone trials no ranking page mentions. We ran PubMed searches for collagen with hot flashes, sleep, mood, weight and postmenopausal muscle outcomes so that “no evidence” is checked, not assumed. We do not test products and have no clinical practice.

The bottom line

Collagen loss after menopause is real and measurable, about 1 to 2% per year in the original data and front-loaded into the first years after the final period. Collagen peptides have modest, instrument-measured benefits for skin in women of this age, and five small, mostly manufacturer-involved trials suggest a small bone-density benefit in postmenopausal women with low bone mass. For hot flashes, sleep, mood and weight there is no human evidence, and products that imply otherwise are selling the word menopause rather than a tested effect.

The trials used 2.5 to 5 grams of hydrolyzed peptides a day for 8 weeks (skin) to 12 months (bone), with calcium and vitamin D in most comparison groups. Our best collagen for women over 50 guide compares products against those trial doses.

Related reading:

• 7 Benefits of Collagen for Women (By Life Stage)
• Best Collagen Supplements for Bone Health
• Collagen for Skin: How It Works and What to Expect
• Collagen for Loose Skin: Does It Actually Help?